Full history for every metric is available with a Kvantra account
Changjiang Runfa Health Industry Co., Ltd. (002435.SZ)
Key financial summary
Financials in CNY| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY m | 4,674 | 5,038 | 4,241 | 4,370 | 3,470 | 3,238 | 3,025 |
| Operating profit | CNY m | -784 | -863 | |||||
| Net profit | CNY m | 367 | -411 | 248 | -416 | 41 | -767 | -837 |
| EPS reported | CNY | -0.62 | -0.68 | |||||
| Operating cashflow per share | CNY | 0.27 | 0.27 | |||||
| Capex per share | CNY | 0.15 | 0.15 | |||||
| FCF per share | CNY | 0.12 | 0.12 | |||||
| Free cash flow | CNY m | 148 | 95 | |||||
| Net debt | CNY m | -286 | 1,323 | |||||
| Book value equity | CNY m | 3,730 | 3,720 | |||||
| Book value per share | CNY | 3.02 | 2.99 | |||||
| Number of shares | m | 1,236.06 | 1,242.88 | |||||
| DPS (TTM paid) | CNY | 0.06 | 0.00 |
Financial summary
Financials in CNY| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.38 | 0.12 | |||||
| P/S LTM | x | 1.59 | 0.15 | |||||
| P/FCF LTM | x | 34.91 | 4.82 | |||||
| EV/EBITDA LTM | x | 30.64 | -27.35 | |||||
| EV/Sales LTM | x | 1.66 | 0.59 | |||||
| Earnings Yield LTM | % | -14.88% | -167.65% | |||||
| FCF Yield | % | 2.86% | 20.74% | |||||
| Quality | ||||||||
| ROE | % | -20.55% | -18.48% | |||||
| ROIC | % | -12.23% | -12.23% | |||||
| Operating margin | % | -24.20% | -24.20% | |||||
| Gross margin | % | 33.36% | 33.36% | |||||
| FCF/Sales | % | 4.56% | 4.56% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -6.67% | -12.01% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | -57.59% | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 1.50% | 0.00% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | -10.08% | -29.17% | |||||
| FCF/Debt | x | 0.06 | 0.04 | |||||
| Net Debt/EBITDA | x | 1.24 | 1.24 | |||||
| EBIT/Net interest | x | -8.50 | -8.50 | |||||
| Net debt/market cap | % | -5.56% | 289.37% | |||||
| Net debt/Equity | x | -0.08 | 0.36 | |||||
| Gross debt/equity | x | 0.64 | 0.61 | |||||
Company overview
Established in 1989 and headquartered in Zhangjiagang, China, Changjiang Runfa Health Industry Co., Ltd. operates both domestically and globally. The company's primary focus involves the research, development, manufacturing, and distribution of pharmaceutical products. Furthermore, it delivers specialized medical care, particularly in obstetrics and gynecology, and also trades mechanical goods, including elevator guide rails.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Changjiang Runfa Health Industry Co., Ltd. (002435.SZ)
Established in 1989 and headquartered in Zhangjiagang, China, Changjiang Runfa Health Industry Co., Ltd. operates both domestically and globally. The company's primary focus involves the research, development, manufacturing, and distribution of pharmaceutical products. Furthermore, it delivers specialized medical care, particularly in obstetrics and gynecology, and also trades mechanical goods, including elevator guide rails.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free